These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 263192)
21. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691 [TBL] [Abstract][Full Text] [Related]
22. FDA electronic drug labels to improve patient safety. J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334 [No Abstract] [Full Text] [Related]
23. FDA cancels plans requiring patient package inserts for drugs. Ob Gyn News; 1982 Mar 1-14; 17(5):5. PubMed ID: 11654881 [No Abstract] [Full Text] [Related]
24. FDA acts on estrogen, progestin labeling. FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006 [No Abstract] [Full Text] [Related]
25. Is the FDA packing a surprise for you? Chapman S Leg Aspects Med Pract; 1979 Nov; 7(11):35-8. PubMed ID: 263195 [No Abstract] [Full Text] [Related]
28. The history of patient package inserts in the United States. Moore SR; Morris LA; Groft SC Can Pharm J; 1981 May; 114(5):173-5. PubMed ID: 10251273 [No Abstract] [Full Text] [Related]
29. Did FDA jump the gun? Archambault GF Hosp Formul; 1977 Oct; 12(10):722. PubMed ID: 10305387 [No Abstract] [Full Text] [Related]
30. Institutional pharmacists' guide to complying with PPI regulations. Greenberg RB Am J Hosp Pharm; 1980 Dec; 37(12):1656-9. PubMed ID: 7446540 [TBL] [Abstract][Full Text] [Related]
31. Patient package inserts--a good idea gone bad. Kough RH Pa Med; 1978 Jul; 81(7):15-6. PubMed ID: 662407 [No Abstract] [Full Text] [Related]
32. Estrogen PPIs. An FDA survey. Morris LA; Myers A; Gibbs P; Lao C Am Pharm; 1980 Jun; NS20(6):22-6. PubMed ID: 7395715 [No Abstract] [Full Text] [Related]
33. AMA readies its version of the PPI. Med World News; 1982 May; 23(11):61, 64. PubMed ID: 10255687 [No Abstract] [Full Text] [Related]
34. Unapproved uses of approved drugs: The physician, the package insert, and the FDA. Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165 [No Abstract] [Full Text] [Related]
35. Patient package inserts-an industry viewpoint. Waife SO Trans Stud Coll Physicians Phila; 1977 Jul; 45(1):4-7. PubMed ID: 617242 [No Abstract] [Full Text] [Related]
36. Patient package inserts--instructions or intrusions? Harvey MW Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481 [No Abstract] [Full Text] [Related]
37. An exploratory study of drug abuse and dependence information in package inserts. Phipps LB; Balster RL; Slattum PW; Kirkwood CK J Addict Dis; 2007; 26(2):25-34. PubMed ID: 17594995 [TBL] [Abstract][Full Text] [Related]
38. FDA chief says demand by patients for more drug information is genuine. Health Educ Rep; 1980 Jul; 2(15):4-5. PubMed ID: 10247629 [No Abstract] [Full Text] [Related]